New Tumor Suppressor MicroRNAs Target Glypican-3 in Human Liver Cancer
Overview
Authors
Affiliations
Glypican-3 (GPC3) is an oncogene, frequently upregulated in liver malignancies such as hepatocellular carcinoma (HCC) and hepatoblastoma and constitutes a potential molecular target for therapy in liver cancer. Using a functional screening system, we identified 10 new microRNAs controlling GPC3 expression in malignant liver cells, five of them e.g. miR-4510, miR-203a-3p, miR-548aa, miR-376b-3p and miR-548v reduce GPC3 expression. These 5 microRNAs were significantly downregulated in tumoral compared to non-tumoral liver and inhibited tumor cell proliferation. Interestingly, miR-4510 inversely correlated with GPC3 mRNA and protein in HCC samples. This microRNA also induced apoptosis of hepatoma cells and blocked tumor growth in vivo in the chick chorioallantoic membrane model. We further show that the tumor suppressive effect of miR-4510 is mediated through direct targeting of GPC3 mRNA and inactivation of Wnt/β-catenin transcriptional activity and signaling pathway. Moreover, miR-4510 up-regulated the expression of several tumor suppressor genes while reducing the expression of other pro-oncogenes. In summary, we uncovered several new microRNAs targeting the oncogenic functions of GPC3. We provided strong molecular, cellular and in vivo evidences for the tumor suppressive activities of miR-4510 bringing to the fore the potential value of this microRNA in HCC therapy.
Non-coding RNAs participate in interactions between senescence and gastrointestinal cancers.
Liu Z, Ji F, Piao Y Front Genet. 2025; 15():1461404.
PMID: 39831201 PMC: 11739115. DOI: 10.3389/fgene.2024.1461404.
Monge C, Frances R, Marchio A, Pineau P, Desterke C, Mata-Garrido J Int J Mol Sci. 2024; 25(23).
PMID: 39684755 PMC: 11641740. DOI: 10.3390/ijms252313044.
Devan A, Nair B, Pradeep G, Alexander R, Vinod B, Nath L Eur J Med Res. 2024; 29(1):490.
PMID: 39369212 PMC: 11453014. DOI: 10.1186/s40001-024-02073-2.
Kadioglu D, Demirtas C, Pirim D, Dilber F, Eren F Hepatol Forum. 2024; 5(3):106-112.
PMID: 39006138 PMC: 11237244. DOI: 10.14744/hf.2023.2023.0054.
The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens.
Tavakoli Pirzaman A, Ebrahimzadeh Pirshahid M, Babajani B, Rahmati A, Niknezhad S, Hosseinzadeh R Technol Cancer Res Treat. 2023; 22:15330338231206003.
PMID: 37849311 PMC: 10586010. DOI: 10.1177/15330338231206003.